Glycophos

Glycophos is a prescription sodium glycerophosphate pentahydrate solution for injection, supplied as an intravenous electrolyte replenisher. It contains the active ingredient sodium glycerophosphate pentahydrate in a sterile aqueous solution intended for parenteral use. Marketed in the European Union, the product is classified as a phosphate supplement used to correct low phosphate levels and related electrolyte disturbances, and is administered by healthcare professionals in clinical settings.

Glycophos is indicated for medical situations where phosphate and sodium replenishment are required, particularly in patients with documented electrolyte deficiencies. It is used under physician supervision to restore normal serum phosphate concentrations and support metabolic functions.

- Treatment of hypophosphatemia resulting from acute or chronic conditions. - Phosphate replacement therapy during renal replacement or dialysis procedures. - Management of electrolyte imbalance in postoperative or critically ill patients. - Support for patients receiving parenteral nutrition who need phosphate supplementation. - Adjunctive therapy in cases of severe burns or extensive trauma where phosphate loss is significant.

Side effects may occur with Glycophos administration; they are categorized by frequency and severity.

Common: - Mild nausea or vomiting. - Transient headache. - Temporary local irritation at the injection site. - Slight increase in serum sodium levels.

Serious: - Severe hyperphosphatemia leading to calcium-phosphate precipitation. - Acute renal dysfunction. - Anaphylactic reaction or severe hypersensitivity.

Healthcare providers should consider several precautions before prescribing Glycophos.

- Assess baseline serum phosphate, calcium, and renal function. - Use caution in patients with existing hyperphosphatemia or hypercalcemia. - Monitor electrolytes regularly during therapy. - Adjust dose in individuals with impaired renal clearance. - Avoid rapid infusion rates to reduce risk of cardiovascular complications. - Pregnant or breastfeeding patients should be evaluated on a case‑by‑case basis.

Glycophos may interact with other medications; awareness of potential interactions helps ensure safety.

Avoid: - Concurrent use of calcium-containing IV solutions, which can precipitate calcium‑phosphate complexes. - High-dose vitamin D supplements that increase calcium absorption.

Use with caution: - Loop diuretics, which may alter electrolyte balance. - ACE inhibitors or ARBs, due to possible effects on renal function. - Antacids containing aluminum or magnesium, which can affect phosphate levels. - Other phosphate binders, which may reduce the efficacy of Glycophos.